Q4 2025 Coromandel International Ltd Earnings Call Transcript
Key Points
- Coromandel International Ltd (BOM:506395) reported a 28% growth in consolidated total income for the quarter and a 10% increase for the full year, driven by volume growth across all business segments.
- The company achieved its highest ever production volume of 33.3 lakh tonnes, with significant improvements in safety and environmental management.
- Coromandel's market share in phosphatic fertilizers improved to 18% from 15% the previous year, with a record sale and consumption of phosphatic fertilizers.
- The Crop Protection business saw a 7% revenue increase, with a 25% rise in PBIT margins due to improved demand for key molecules and new product performance.
- The company expanded its retail footprint by adding 130 new centers and plans to triple its retail presence in the coming years, with 99% of stores currently profitable.
- The company faces challenges with high sulphur and sulphuric acid prices, which have impacted margins.
- There are concerns about the high debt levels and interest costs associated with the acquisition of NACL Industries.
- The domestic formulation market in Crop Protection is experiencing pricing pressure, affecting profitability.
- The company is facing capacity constraints in manufacturing, which may lead to higher trading portions in the short term.
- The integration and turnaround of NACL Industries may take time, with regulatory approvals still pending and operational improvements needed.
Ladies and gentlemen, good day, and welcome to Coromandel International Limited Q4 FY '25 Earnings Call hosted by Nirmal Bang Institutional Equities Private Limited. (Operator Instructions). Please note that this conference is being recorded.
I now hand the conference over to Mr. S. Ramesh. Thank you. And over to you, sir.
Good afternoon, ladies and gentlemen. On behalf of Nirmal Bang Equities, I have great pleasure in inviting all of you for the 4Q FY '25 earnings call with the management of Coromandel International. The company is represented by Mr. Sankarasubramanian, MD and CEO; Dr. Raghuram Devarakonda, Executive Director, CPC, Bio and Retail; Mrs. Jayashree Satagopan, President Corporate; and the new CFO, Mr. Deepak Natarajan.
So let me hand over the call to Sankar for his opening remarks. Over to you, sir.
Good afternoon,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
